Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3011% below fair value
$0.94−0.07 (-6.71%)
Close on Nov 20, 2026Market cap $94.41MP/E –Yield –
Stereotaxis net income
Net income is the profit left for shareholders after every expense, interest and tax.
Stereotaxis's net income for the twelve months ending Jun 30, 2026 was -$22.32M. For fiscal 2025 it was -$21.64M. The highest annual figure on record is $116.76K in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$21.64M | – |
| FY2024 | Dec 31, 2024 | -$24.05M | – |
| FY2023 | Dec 31, 2023 | -$20.71M | – |
| FY2022 | Dec 31, 2022 | -$18.29M | – |
| FY2021 | Dec 31, 2021 | -$10.72M | – |
| FY2020 | Dec 31, 2020 | -$6.65M | – |
| FY2019 | Dec 31, 2019 | -$4.59M | -4032.4% |
| FY2018 | Dec 31, 2018 | $116.76K | – |
| FY2017 | Dec 31, 2017 | -$5.89M | – |
| FY2016 | Dec 31, 2016 | -$5.29M | – |
| FY2015 | Dec 31, 2015 | -$7.35M | – |
| FY2014 | Dec 31, 2014 | -$5.20M | – |
| FY2013 | Dec 31, 2013 | -$68.76M | – |
| FY2012 | Dec 31, 2012 | -$9.24M | – |
| FY2011 | Dec 31, 2011 | -$32.03M | – |
| FY2010 | Dec 31, 2010 | -$19.92M | – |
| FY2009 | Dec 31, 2009 | -$27.49M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.47M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.86M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.53M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.46M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.83M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.82M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.19M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.04M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.37M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.35M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.92M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.13M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.09M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.36M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.62M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.21M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.53M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.18M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.57M | -3695.5% |
| Q2 FY2020 | Jun 30, 2020 | -$1.92M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.97M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.08M | – |
| Q3 FY2019 | Sep 30, 2019 | $43.75K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.43M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.12M | -247.9% |
| Q4 FY2018 | Dec 31, 2018 | -$569.97K | – |
| Q3 FY2018 | Sep 30, 2018 | -$116.30K | – |
| Q2 FY2018 | Jun 30, 2018 | -$632.21K | – |
| Q1 FY2018 | Mar 31, 2018 | $1.44M | +21.9% |
| Q4 FY2017 | Dec 31, 2017 | -$2.55M | -146.1% |
| Q3 FY2017 | Sep 30, 2017 | -$4.33M | – |
| Q2 FY2017 | Jun 30, 2017 | -$177.30K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.18M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.53M | – |
| Q3 FY2016 | Sep 30, 2016 | -$6.21M | – |
See a number that looks wrong?